NOTCH1 and cancer: Notably, penSCC (17%) and vulSCC (17%) frequently harbored mutations in the NOTCH1 pathway that was found to be implicated in cancer development.42-44NOTCH1 inhibition can be achieved through different pathways, among those the most common is through the g-secretase inhibitors, which produce a pan-NOTCH inhibition.